Department of Paediatric Cardiology, Great Ormond Street Hospital for Children, London, UK.
Arch Dis Child. 2011 Feb;96(2):141-7. doi: 10.1136/adc.2009.169904. Epub 2010 Oct 7.
To assess the relationship between 6-min walk test (6MWT) distance and variables of cardiopulmonary exercise testing (CPET) in children with pulmonary arterial hypertension (PAH).
Retrospective study.
Tertiary hospital.
Children with PAH.
CPETs and 6MWTs.
Correlations between variables of CPET and 6MWT distance.
41 exercise studies were included: 15 in children with idiopathic PAH (mean age 13.0±3.0 years; 9 female), 18 in children with PAH associated with congenital heart disease (age 14.8±2.8 years; 7 female) and 8 in children with Eisenmenger syndrome (age 11.8±2.9 years; 4 female). All underwent a CPET and 6MWT. Peak oxygen consumption (pVO(2)) and 6MWT distance were reduced to 31.5±12.2% and 47.7±16.7% of the predicted value, respectively (p<0.0001 for both). pVO(2) and oxygen consumption at anaerobic threshold showed correlation with 6MWT distance (r=0.49; p=0.001 and r=0.40, p=0.01, respectively), while an inverse correlation was found between measures of ventilatory efficiency (eg, VE/VCO(2)) at anaerobic threshold and 6MWT distance (r=-0.43; p=0.005). There was a significant linear relationship between pVO(2) and 6MWT up to a distance of 300 m, with the 6MWT distance accounting for 71% of the variation in pVO(2) but there was hardly any association when the 6MWT distance was >300 m.
The 6MWT reflects maximal exercise capacity in patients with a 6MWT distance below 300 m. A CPET should therefore be considered as a complimentary test in children with an exercise tolerance above this threshold. These findings may have implications for assessing response to drug therapy and for consideration as an end point in future PAH trials.
评估 6 分钟步行试验(6MWT)距离与肺动脉高压(PAH)患儿心肺运动试验(CPET)各项变量之间的关系。
回顾性研究。
三级医院。
PAH 患儿。
CPET 和 6MWT。
CPET 各项变量与 6MWT 距离之间的相关性。
纳入 41 项运动研究:15 项特发性 PAH 患儿(平均年龄 13.0±3.0 岁;9 名女性),18 项先心病相关 PAH 患儿(年龄 14.8±2.8 岁;7 名女性),8 项艾森曼格综合征患儿(年龄 11.8±2.9 岁;4 名女性)。所有患儿均接受 CPET 和 6MWT。峰值氧耗量(pVO2)和 6MWT 距离分别下降至预计值的 31.5±12.2%和 47.7±16.7%(均 P<0.0001)。pVO2 和无氧阈时的氧耗量与 6MWT 距离呈正相关(r=0.49;P=0.001 和 r=0.40,P=0.01),而无氧阈时的通气效率(如 VE/VCO2)指标与 6MWT 距离呈负相关(r=-0.43;P=0.005)。pVO2 与 6MWT 距离之间存在显著的线性关系,在 300 m 范围内,6MWT 距离可解释 pVO2 变化的 71%,但在 6MWT 距离>300 m 时几乎没有相关性。
6MWT 可反映 6MWT 距离<300 m 的患者的最大运动能力。因此,对于运动耐量高于该阈值的患儿,CPET 应作为补充试验。这些发现可能对评估药物治疗反应以及作为未来 PAH 试验的终点具有重要意义。